Insider Buying: Femasys (NASDAQ:FEMY) CFO Purchases $50,000.00 in Stock

Femasys Inc. (NASDAQ:FEMY) CFO Dov Elefant bought 15,625 shares of Femasys stock in a transaction that occurred on Friday, August 7th. The stock was purchased at an average price of $3.20 per share, with a total value of $50,000.00. Following the purchase, the chief financial officer directly owned 15,625 shares in the company, valued at $50,000. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Femasys Stock Down 2.6%

Shares of FEMY stock opened at $2.29 on Friday. Femasys Inc. has a fifty-two week low of $2.19 and a fifty-two week high of $22.20. The firm has a market capitalization of $6.92 million, a PE ratio of -0.42 and a beta of -2.08. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.98 and a current ratio of 3.91. The stock’s 50-day simple moving average is $3.67 and its 200-day simple moving average is $7.35.

Wall Street Analyst Weigh In

Several brokerages have commented on FEMY. Weiss Ratings upgraded shares of Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 31st. Wall Street Zen upgraded shares of Femasys to a “hold” rating in a research note on Saturday, June 13th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Femasys currently has a consensus rating of “Hold” and a consensus price target of $80.00.

Institutional Trading of Femasys

A number of hedge funds have recently modified their holdings of the stock. Cetera Investment Advisers acquired a new stake in Femasys during the fourth quarter worth about $36,000. Kovack Advisors Inc. acquired a new position in Femasys in the fourth quarter valued at approximately $27,000. State Street Corp lifted its holdings in Femasys by 43.5% in the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock valued at $47,000 after acquiring an additional 24,500 shares during the period. Jane Street Group LLC purchased a new stake in Femasys in the 4th quarter worth approximately $62,000. Finally, HRT Financial LP purchased a new stake in Femasys in the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.